The world’s only searchable, sortable database of 300+ investors who are actively investing in regenerative medicine (RM) and advanced therapy (AT) companies.
Regenerative medicine companies are defined as those involved with cell therapies, gene therapies, exosomes, tissue engineering, biomaterials, or other related therapies involving the use of human cells and tissues.
Gene therapy is the use of genetic material to change the expression of a gene product, while cell therapies utilize living cells to create either direct or indirect effects within the human body. Exosomes exert their effects by carrying cell-specific cargos which are selectively taken up by recipient cells. Likewise, there are technologies that can impact the health of tissues and organs through the use of biomaterials, tissue engineering, and 3D bioprinting.
To develop these novel regenerative medicine (RM) and advanced therapy (AT) products, investor capital is often needed to support these therapeutics from preclinical development through clinical trials, and ultimately, to commercialization.
Regenerative medicine industry investors include:
- Venture Capital Groups
- Private Equity Firms
- Hedge Funds
- Investment Firms
- Endowment Funds
- Angel Investors (for example, Tony Robbins, Bill Maris, Peter Diamandis and others)
Database of Regenerative Medicine (RM) Investors
This database reveals the identity and investment behavior of over 300 investors who specialize in companies commercializing regenerative medicine (RM) and advanced therapy (AT) products.
It was originally developed in-house for our own purposes, but we had clients repeatedly requesting access to it. Because it is an essential resource within our company, we are confident it will be a valuable resource for you too.
This comprehensive global database includes:
- Investor Identity (Individual or Company Name)
- Type of Investor
- Year Founded
- Company Website
- Regenerative Medicine (RM) Companies Funded
- Description of the Investor
- Phone Number
- Email Address
Use this database if you plan to pursue:
- Seed rounds
- Venture rounds
- Private placements
- Loans and convertible debt
- Any activity requiring external funding
It can also be used to strengthen your network by identifying the regenerative medicine (RM) industry’s most influential investors. Imagine being immediately informed about investor profiles and preferences, without conducting weeks of unnecessary research.